Description: MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease, fatigue of MS and cancer. The majority owned Xenogenics subsidiary is developing a drug-eluting cardiac stent.
Home Page: www.multicelltech.com
68 Cumberland Street
Woonsocket,
RI
02895
United States
Phone:
401-762-0045
Officers
| Name | Title |
|---|---|
| Mr. W. Gerald Newmin | Chairman, CEO, Pres, CFO, Treasurer & Sec. |
| Ms. Barbara Corbett | Mang. of Investor Relations |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0.0124 |
| IPO Date: | |
| Fiscal Year End: | November |
| Full Time Employees: | 2 |